Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence.
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?CB2 Cannabinoid Receptor As Potential Target against Alzheimer's DiseasePerinatal asphyxia results in altered expression of the hippocampal acylethanolamide/endocannabinoid signaling system associated to memory impairments in postweaned rats.Palmitoylethanolamide counteracts reactive astrogliosis induced by β-amyloid peptideTracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging.The endocannabinoid system as a target for the treatment of neurodegenerative disease.Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target.Promising cannabinoid-based therapies for Parkinson's disease: motor symptoms to neuroprotectionCannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of NeuroinflammationCannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation.Targeting the endocannabinoid system: to enhance or reduce?WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.The endocannabinoid system as a target for the treatment of neuronal damage.The therapeutic potential of the endocannabinoid system for Alzheimer's disease.The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects.Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.Rising stars: modulation of brain functions by astroglial type-1 cannabinoid receptors.Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?Endocannabinoid system in neurodegenerative disorders.Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS.β-Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB₁ or CB₂ receptors.AM1241 alleviates MPTP-induced Parkinson's disease and promotes the regeneration of DA neurons in PD mice.Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer's Disease but Plays a Minor Role in the Therapeutic Properties of a Cannabis-Based Medicine.Endocannabinoids alleviate proinflammatory conditions by modulating innate immune response in muller glia during inflammation.Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer's disease.
P2860
Q24633122-E044D32C-CC33-48D3-85A4-B0F424A15A47Q26746050-EEAEABAF-3C00-4C7B-9473-6580C8FFC147Q27322965-CBF39107-20F3-43FE-8CDB-1DE181873B80Q28390536-2CD3577C-4648-47C4-806D-E2E3080BE34EQ33904501-C3B5F073-4E0F-45D0-BF0B-EE251BB85816Q34098196-D6D61CD9-9C13-4F3B-A0D4-21060A9B93B9Q34680801-70E7A151-9266-48E0-90A6-4E908F3309A0Q35499568-1BE8A3CA-0C84-403E-9C70-56E8BFB314D4Q35667387-B6581406-1554-439D-823D-38E4A2CF8B90Q37143569-51AA5A56-E7AB-445C-8699-158A35898AB7Q37150745-ADE67C27-D379-42FB-941F-088AD6634840Q37371387-01590164-6D62-4E48-BEE1-03068728BD0CQ37709370-BF013AF0-D317-4326-8284-81A0EFA8C758Q37997020-D5D514A1-44F6-4C16-8ABD-8A02812BC915Q38072364-EC5AA6C9-2342-4D55-A2F2-7E2E0FDA2B97Q38196398-05D003E7-3EFF-41BE-841B-F3192A80E39BQ38276026-ADBC7CDC-A6C9-421E-962B-DBDB4BECA4AEQ38748394-69D9345B-DDF7-4456-B3A2-95241733B80AQ39368845-073B6001-4D12-489F-B65F-471D24258199Q42248889-73B2B8DD-73FC-4D39-8801-51C52CE771E6Q42272971-CE6EA870-4447-4179-BB93-4CC971368E12Q42366580-CD927535-B046-4537-8136-FDC455D53D28Q48895791-6739D782-EC6C-4183-B0FA-8F876D686FEDQ53102889-DECDC53B-937D-48C6-9493-3EADCFA02DCAQ55078779-487EC0B9-6900-4D11-89C5-001A7E36962C
P2860
Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Opposing control of cannabinoi ...... in vitro and in vivo evidence.
@en
Opposing control of cannabinoi ...... in vitro and in vivo evidence.
@nl
type
label
Opposing control of cannabinoi ...... in vitro and in vivo evidence.
@en
Opposing control of cannabinoi ...... in vitro and in vivo evidence.
@nl
prefLabel
Opposing control of cannabinoi ...... in vitro and in vivo evidence.
@en
Opposing control of cannabinoi ...... in vitro and in vivo evidence.
@nl
P2093
P50
P921
P356
P1476
Opposing control of cannabinoi ...... in vitro and in vivo evidence.
@en
P2093
Claudia Savani
Daniele De Filippis
Teresa Iuvone
P304
P356
10.1124/JPET.107.121566
P407
P577
2007-06-01T00:00:00Z